Chinese herbal medicine Shenqi compound for early intervention in patients at high cardiovascular risk of type 2 diabetes mellitus: the protocol of a multicenter, randomized, double-blind, placebo-controlled trial

Chinese herbal medicine Shenqi compound for early intervention in patients at high cardiovascular risk of type 2 diabetes mellitus: the protocol of a multicenter, randomized, double-blind, placebo-controlled trial

IntroductionReducing multiple cardiovascular risk factors is a key link and a challenging clinical problem to reduce the risk of cardiovascular complications and death in patients with diabetes. Currently, there is a lack of clinical studies on patients with diabetes combined with multiple risk fact...

Full description

Bibliographic Details
Main Authors: Yulin Leng, Zehua Zhang, Nairong Yao, Xiaoxu Fu, Hongyan Xie, Hong Gao, Chunguang Xie
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-01-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
type 2 diabetes mellitus
cardiovascular risk
randomized controlled trial
traditional Chinese medicine
Shenqi compound
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2023.1290240/full

Internet

https://www.frontiersin.org/articles/10.3389/fcvm.2023.1290240/full

Similar Items